Continuing Education

How the immune system is unleashed to fight cancer

How the immune system is unleashed to fight cancer

By

Cancer cells hide from the body's natural defenses. This overview explains how immunotherapeutic strategies expose cancer cells to the immune system.

Understanding current and emerging therapies for HNC

Understanding current and emerging therapies for HNC

By

Head and neck cancer treatments have high morbidity rates. Newer options reduce morbidities and offer patients better quality of life after treatment.

Vertebroplasty is effective for managing myelomatous VCFs

Vertebroplasty is effective for managing myelomatous VCFs

The minimally invasive procedure provides effective, immediate relief from the pain of vertebral compression fractures due to multiple myeloma.

Pain management in patients receiving palliative care

Pain management in patients receiving palliative care

Understanding pain mechanisms and the types, triggers, and alleviating factors is needed to provide effective analgesia for patients with cancer.

Non-small cell lung cancer: Molecular targets and 
emerging options for care

Non-small cell lung cancer: Molecular targets and 
emerging options for care

This activity from myCME offers a review of groundbreaking molecular research and novel treatment options for patients with NSCLC.

Managing chemotherapy side effects: Tumor lysis syndrome

Managing chemotherapy side effects: Tumor lysis syndrome

Patients undergoing chemotherapy for hematologic cancers are at risk for this complication. The review can help you learn how to assess their risk.

Meeting the billing challenges inherent with clinical trials

Meeting the billing challenges inherent with clinical trials

A primer on what nurses need to know when scheduling items and services for patients participating in clinical trials.

Understanding the impact of disparities on cancer care

Understanding the impact of disparities on cancer care

By

Learn how patients' perceptions of health care can have a significant influence on the effectiveness of cancer care and patient education.

GVHD in pediatric HSCT patients: Clinical trials for Rituximab

GVHD in pediatric HSCT patients: Clinical trials for Rituximab

The CD20 antagonist is a potentially effective preventive and treatment for this common adverse effect of hematopoietic stem cell transplantation.

Using anticoagulants to treat chemotherapy-related VTE

Using anticoagulants to treat chemotherapy-related VTE

Signs and symptoms of venous thromboembolism in oncology patients should be heeded with prompt therapeutic and mechanical interventions.

Leukemia: Understanding its types and treatments

Leukemia: Understanding its types and treatments

By

This review describes the four major groups of leukemia, plus diagnostic tests and treatment regimens for each group.

Using ESAs in patients with cancer-related anemia

Using ESAs in patients with cancer-related anemia

Although the risks of erythropoietin-stimulating agents can outweigh the benefits, select patients may benefit.

Troubleshooting complications of vascular access devices

Troubleshooting complications of vascular access devices

VADs enable long-term IV therapy; however, the devices and their use pose a unique set of challenges for nurses.

CIPN: Treatment preservation and prevention are the goals

CIPN: Treatment preservation and prevention are the goals

CIPN is a debilitating adverse effect that can lead to reduced doses that hinder treatment effectiveness or early discontinuation of therapy.

Understanding ototoxicity risks for pediatric oncology patients

Understanding ototoxicity risks for pediatric oncology patients

Audiometric testing, awareness of the symptoms, and knowledge of which drugs are ototoxic can help protect young cancer patient's hearing.

Differentiating type is key to non-Hodgkin lymphomas

Differentiating type is key to non-Hodgkin lymphomas

By

Management and prognosis for patients with NHL depend on identifying the disease type. This review discusses the diagnoses and optimal treatments.

Lynch syndrome: Identifying patients at risk for HNPCC

Lynch syndrome: Identifying patients at risk for HNPCC

Identifying families at risk improves screening and counseling of patients at risk for hereditary nonpolyposis colorectal cancer.

Cancer-related fatigue: Elusive causes challenge treatment

Cancer-related fatigue: Elusive causes challenge treatment

By

Effective management of this nonspecific and varied symptom is based on the underlying mechanisms of action.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs